MedTrace Logo

Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)

NCT03014544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 585

Last updated 2025-04-27

No results posted yet for this study

Summary

The purpose of this study is to examine concurrent validity of 8 computerized tests intended for the assessment of cognitive function in participants with Major Depressive Disorder (MDD), relative to 8 corresponding and previously validated examiner-administered cognitive tests.

Conditions

  • Depressive Disorder, Major

Interventions

DEVICE

Computer- administered test battery

Participants in this observational study will only undergo sequential cognitive performance evaluations by computer- administered cognitive test battery.

DEVICE

Examiner- administered test battery

Participants in this observational study will only undergo sequential cognitive performance evaluations by examiner- administered cognitive test battery.

Sponsors & Collaborators

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC Clinical Trial · Janssen Research & Development, LLC

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-26
Primary Completion
2019-04-08
Completion
2019-04-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014544 on ClinicalTrials.gov